Choose San Francisco Business Times as a preferred news source to see more of our reporting on Google. It is the first work ...

Steve Perry, former frontman of rock band Journey and one-time Larkspur resident, is auctioning off a rare collection of ...

The loss of domvanalimab is the latest in a string of high-profile failures recorded across the biopharma world for the TIGIT ...

Arcus will now refocus its efforts outside of TIGIT, specifically on its asset casdatifan, an HIF-2a inhibitor once backed by Gilead, as well as its earlier stage small-molecule inflammatory and ...

A study using TIGIT and PD-1 drugs for gastrointestinal disease was canceled for “futility” at an early checkpoint, another ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Three-quarters of those surveyed said the program’s resources helped reduce unwanted physical side effects, and more than 80% said it lessened at least one aspect of financial stress. Overall, 85% ...

BAY AREA LEADERS AND GAY RIGHTS advocates gathered in San Francisco to honor community members and commemorate World AIDS Day.  Tweed suits and feathered Bay Area leaders and LGBTQ advocates gathered ...

Deeply experienced industry leaders further strengthen Comanche’s leadership and expertise as it advances CBP-4888 as a potential global solution ...

Gilead Sciences hired Bristol Myers Squibb alum Bob Allen as head of omnichannel strategy and digital transformation for public affairs. Ralph Abraham, who is Louisiana ‘s surgeon general, has been ...

WASHINGTON (Reuters) -About 1,000 doses of Gilead Sciences Inc's drug lenacapavir were delivered to Zambia and Eswatini last Thursday, U.S. and company officials said, the first delivery under a U.S.